user
menu
letter
Sign InRegister
langEnglisharrow

Overview

Disease Areas represent key therapeutic fields driving biologics innovation, where complex biology demands highly relevant, high-quality research tools for target validation, mechanism study, and drug candidate screening. These areas include Autoimmune Diseases, Oncology, Neurodegenerative Diseases, and Metabolic Disorders & Obesity, covering the most critical challenges in global healthcare. At ACROBiosystems, we provide a comprehensive portfolio of recombinant proteins, antibodies, functional cell lines, and assay kits tailored to each disease area, enabling efficient drug discovery and translational research from early target exploration to preclinical and clinical development.
Overview

Featured Articles

Pathological Protein Seeding: Why PFFs MatterHot

Sep 18, 2026

Hot Pathological Protein Seeding: Why PFFs Matter

Pre-formed fibrils (PFFs) provide defined experimental seeds for modeling these processes, enabling researchers to investigate protein aggregation, cellular uptake, pathological propagation, and therapeutic responses across diverse disease models.

Read more
"Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP-43-Driven Pathogenesis in ALSHot

Aug 20, 2026

Hot "Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP-43-Driven Pathogenesis in ALS

ALS remains a major challenge in neurodegenerative disease research, with TDP-43 pathology playing a key role. A recent Nature Aging study introduces a new therapeutic concept: selectively suppressing TDP-43 toxicity while preserving its physiological function.

Read more
The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain AgingHot

Jul 31, 2026

Hot The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging

This article explores how modern neuroscience is decoding healthy brain aging, highlighting the research tools accelerating discoveries in brain longevity and Alzheimer’s disease.

Read more

Explore by Subtopics

Sigvotatug Vedotin: A Breakthrough in Integrin αvβ6 ADC Therapy for Solid TumorsHot
Feb 13, 2025|Disease Areas

Sigvotatug Vedotin: A Breakthrough in Integrin αvβ6 ADC Therapy for Solid Tumors

Potential “Best-in-Class”TL1A Therapy Shows Promising IBD ReliefHot
Mar 11, 2025|Disease Areas

Potential “Best‑in‑Class”TL1A Therapy Shows Promising IBD Relief

World Inflammatory Bowel Disease Day | ACRO Stands with You in Safeguarding Intestinal HealthHot
May 15, 2025|Disease Areas

World Inflammatory Bowel Disease Day | ACRO Stands with You in Safeguarding Intestinal Health

Pathological Protein Seeding: Why PFFs Matter
Sep 18, 2026|Disease Areas

Pathological Protein Seeding: Why PFFs Matter

"Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP-43-Driven Pathogenesis in ALS
Aug 20, 2026|Disease Areas

"Detoxify and Preserve": A New Therapeutic Concept to Tackle TDP‑43‑Driven Pathogenesis in ALS

The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging
Jul 31, 2026|Disease Areas

The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging

Beyond Aβ Deposition: What Drives Progression to Dementia?
Jul 13, 2026|Disease Areas

Beyond Aβ Deposition: What Drives Progression to Dementia?

Next-Generation Obesity Target Spotlight: Activin E for Fat Loss with Muscle Preservation
May 18, 2026|Disease Areas

Next‑Generation Obesity Target Spotlight: Activin E for Fat Loss with Muscle Preservation

Resources

Solutions for Autoimmune Disease Drug Development

Solutions for Autoimmune Disease Drug Development

Request PDF
Aneuro-Advance Neuroscience Research-202303-EN

Aneuro-Advance Neuroscience Research-202303-EN

Request PDF
Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Request PDF
Solutions for Autoimmune Disease Drug Development

Solutions for Autoimmune Disease Drug Development

Request PDF
Aneuro-Advance Neuroscience Research-202303-EN

Aneuro-Advance Neuroscience Research-202303-EN

Request PDF
Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Solutions for Diabetes-Related and Weight-Management Metabolic Disease Drug Development

Request PDF

Webinars

1/2
webinar
play
webinar
play
webinar
play
webinar
play
webinar
play
webinar
play
webinar
play

Related Products and Solutions

Aneuro, Advance Neuroscience Research

Learn More

自己免疫疾患における新薬開発のインスパレーション

Learn More

Metabolic Disease Drug Development Tools

Learn More

Aneuro, Advance Neuroscience Research

Learn More

自己免疫疾患における新薬開発のインスパレーション

Learn More

Metabolic Disease Drug Development Tools

Learn More

Frequently Asked Questions

Q

Why are biomarkers important in translational research?

Biomarkers are important in translational research because they provide measurable indicators of biological processes, disease status, or treatment response. They can support patient stratification, target engagement analysis, response monitoring, and safety assessment. In targeted therapy development, biomarkers may also help identify patient populations most likely to benefit from a specific treatment. By linking laboratory findings with clinical outcomes, biomarkers help improve the efficiency and success of translational development.
Q

How are therapeutic targets identified in disease research?

Therapeutic targets are identified by evaluating a molecule’s role in disease mechanisms and its potential for therapeutic intervention. Researchers often assess genetic evidence, abnormal protein expression, pathway relevance, disease specificity, and differences between diseased and healthy tissues. A strong target should have clear biological relevance and a favorable safety window. Functional validation in relevant preclinical models is then needed to confirm that modulating the target can produce the desired biological effect.
Q

How does disease biology guide drug discovery?

Disease biology provides the foundation for modern drug discovery by helping researchers understand the mechanisms, pathways, and cellular interactions that drive disease. This understanding supports the identification of therapeutic targets, disease-relevant biomarkers, and appropriate experimental models. It also helps researchers connect biological mechanisms with therapeutic strategies more effectively. Relevant disease models, including advanced in vitro systems such as organoids, can further support drug screening, target validation, and translational research.

Explore More Topics

Cell and Gene Therapy

Cell and Gene Therapy

Antibody-Drug Conjugates

Antibody-Drug Conjugates

CMC Manufacturing & QC

CMC Manufacturing & QC

Bispecific Antibodies

Bispecific Antibodies

Vaccines

Vaccines

Research & Innovation

Research & Innovation

Biomarker-Driven Bioanalysis

Biomarker-Driven Bioanalysis